Pneumonia

Medicine (United Kingdom)

Volumn 40, Issue 6, 2012, Pages 329-334

  Loebinger, Michael R ^a,b   Wilson, Robert ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

antibiotics; bacteria; community acquired pneumonia; infection; pneumonia; vaccination

Indexed keywords

AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CLARITHROMYCIN; DOXYCYCLINE; FLUCLOXACILLIN; LINEZOLID; MACROLIDE; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BRONCHIECTASIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; CLINICAL ASSESSMENT; CYSTIC FIBROSIS; DISEASE SEVERITY; EMERGENCY WARD; ESCHERICHIA COLI; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL ADMISSION; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INNATE IMMUNITY; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LEGIONELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; MORTALITY; MYCOPLASMA PNEUMONIAE; PATHOGENESIS; PATHOLOGY; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 84862102006     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2012.03.005     Document Type: Review

References (28)

1. I. Rudan, C. Boschi-Pinto, Z. Biloglav, K. Mulholland, and H. Campbell Epidemiology and etiology of childhood pneumonia Bull World Health Organ 86 2008 408 416 (Pubitemid 351694322)
2. W.S. Lim, S.V. Baudouin, and R.C. George BTS guidelines for the management of community acquired pneumonia in adults: update 2009 Thorax 64 suppl 3 2009 iii1 55
3. E.M. Mortensen, W.N. Kapoor, C.C. Chang, and M.J. Fine Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia Clin Infect Dis 37 2003 1617 1624 (Pubitemid 37549947)
4. R.G. Masterton, A. Galloway, and G. French Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy J Antimicrob Chemother 62 2008 5 34 (Pubitemid 351865870)
5. M.T. Kauppinen, P. Saikku, P. Kujala, E. Herva, and H. Syrjala Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia Thorax 51 1996 185 189 (Pubitemid 26060656)
6. L.C. Jennings, T.P. Anderson, and K.A. Beynon Incidence and characteristics of viral community-acquired pneumonia in adults Thorax 63 2008 42 48
7. M.J. Fine, T.E. Auble, and D.M. Yealy A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250 (Pubitemid 27044625)
8. W.S. Lim, M.M. van der Eerden, and R. Laing Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 2003 377 382 (Pubitemid 36560938)
9. F.W. Arnold, J.A. Ramirez, L.C. McDonald, and E.L. Xia Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment Chest 124 2003 121 124 (Pubitemid 36851342)
10. P.G. Charles, R. Wolfe, and M. Whitby SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia Clin Infect Dis 47 2008 375 384 (Pubitemid 352009359)
11. L.A. Mandell, R.G. Wunderink, and A. Anzueto Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 suppl 2 2007 S27 S72
12. L.M. Baddour, V.L. Yu, and K.P. Klugman Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia Am J Respir Crit Care Med 170 2004 440 444 (Pubitemid 39214620)
13. P.M. Houck, D.W. Bratzler, W. Nsa, A. Ma, and J.G. Bartlett Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia Arch Intern Med 164 2004 637 644 (Pubitemid 38392978)
14. T.P. Meehan, M.J. Fine, and H.M. Krumholz Quality of care, process, and outcomes in elderly patients with pneumonia J Am Med Assoc 278 1997 2080 2084 (Pubitemid 28016230)
15. M. Kanwar, N. Brar, R. Khatib, and M.G. Fakih Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule Chest 131 2007 1865 1869 (Pubitemid 46981647)
16. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 2005 388 416
17. S. Ewig, T. Welte, J. Chastre, and A. Torres Rethinking the concepts of community-acquired and health-care-associated pneumonia Lancet Infect Dis 10 2010 279 287
18. M.C. Pasteur, D. Bilton, and A.T. Hill British Thoracic Society guideline for non-CF bronchiectasis Thorax 65 suppl 1 2010 i1 58
19. D. Peckham, and M.W. Elliott Pulmonary infiltrates in the immunocompromised: diagnosis and management Thorax 57 suppl 2 2002 II3 II7
20. L.M. Dunbar, R.G. Wunderink, and M.P. Habib High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm Clin Infect Dis 37 2003 752 760 (Pubitemid 37153652)
21. R. el Moussaoui, C.A. de Borgie, and P. van den Broek Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study Br Med J 332 2006 1355
22. J. Johnstone, T.J. Marrie, D.T. Eurich, and S.R. Majumdar Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia Arch Intern Med 167 2007 1938 1943 (Pubitemid 47606632)
23. A. Tejera, F. Santolaria, and M.L. Diez Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response Cytokine 38 2007 117 123 (Pubitemid 47248295)
24. M. Christ-Crain, D. Stolz, and R. Bingisser Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial Am J Respir Crit Care Med 174 2006 84 93 (Pubitemid 43955248)
25. P.R. Myles, R.B. Hubbard, J.E. Gibson, Z. Pogson, C.J. Smith, and T.M. McKeever The impact of statins, ACE inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort Pharmacoepidemiol Drug Saf 18 2009 697 703
26. G. Voiriot, S. Dury, A. Parrot, C. Mayaud, and M. Fartoukh Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia Chest 139 2011 387 394
27. A. Singanayagam, J.D. Chalmers, and A.T. Hill Inhaled corticosteroids and risk of pneumonia: evidence for and against the proposed association QJM 103 2010 379 385
28. I. Douglas, S. Evans, and L. Smeeth Effect of statin treatment on short term mortality after pneumonia episode: cohort study Br Med J 342 2011 d1642